Tracked provider

GoodRx tirzepatide review

GoodRx (NASDAQ: GDRX) is the largest US prescription savings platform.

This is a tracked entry: the facts below are what GoodRx publishes about itself, recorded and re-checked as part of the board we maintain (last checked 2026-07-25). Our hand-written reviews go deeper on the programs people ask about most. Prices change — confirm on GoodRx's own site before you pay.

What it costs

Tirzepatide: $299/mo (brand Zepbound)
What is dispensed: Brand tirzepatide (Zepbound / Mounjaro)
Who compounds it: Pharmacy (brand)

How the program works

Serves all 50 states.

What we like

$149/month self-pay for brand-name Foundayo (orforglipron) — matches the lowest cash price at launch, far below typical retail
$299/month self-pay for Zepbound KwikPen — well under Lilly's typical cash list price
Honored at 70,000+ US pharmacies — the largest retail redemption network of any GLP-1 channel we cover
No membership fee — bring your own prescription and present the discount card at the pharmacy counter
Brand-name FDA-approved medication, not compounded

The caveats

Requires a valid prescription — GoodRx is a discount card, not a prescriber; you still need a clinician to write the script
Self-pay only — does not apply toward insurance benefits or deductibles
Headline price applies to the lowest Foundayo dose; higher doses may cost more
No compounded GLP-1 options — not the channel for compounded semaglutide or tirzepatide
Pricing can change as Lilly's manufacturer coupon program evolves

Ready to look at GoodRx directly? The link below is tracked so we can see it worked; it goes to their own site.

Visit GoodRx

Advertising disclosure — some, not all, of the providers ranked here are partners, and we may earn a commission at no additional cost to you. The prices and facts we report come from each provider's own published program. Full disclosure.

Other tirzepatide programs we track

← Every provider review